Tech Center 1600 • Art Units: 1648 1657
This examiner grants 47% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17834232 | HIGH FREQUENCY APPLICATION OF BOTULINUM TOXIN THERAPY | Final Rejection | MERZ PHARMA GmbH & CO. KGaA |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy